Journal of Pharmaceutical Analysis (Mar 2024)
Active components of Dengzhan Shengmai ameliorate cognitive impairment by facilitating hippocampal long-term potentiation via the NMDA receptor-mediated Ca2+/CaMKII pathway
Abstract
No abstracts available.